Siemens Healthineers sharpens ultrasound focus: stock pre-market at EUR 39.55
Published on 10/13/2026 at 08:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Siemens Healthineers published an ultrasound strategy update on October 12, 2026.
- The company is focusing its ultrasound business on procedural imaging and image-guided therapy.
- The stock was at EUR 39.55 pre-market at Lang & Schwarz at 8:01 a.m. CEST on October 13, 2026.
Siemens Healthineers said on October 12, 2026, that it is sharpening its ultrasound focus on procedural imaging and image-guided therapy. At Lang & Schwarz, Siemens Healthineers stock was at EUR 39.55 on October 13, 2026, at 8:01 a.m. CEST.
Pre-market price
The company’s bid was EUR 39.35 and its ask was EUR 39.75 at Lang & Schwarz. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Ultrasound strategy
According to the Siemens Healthineers press release, the business will concentrate on cardiovascular interventions, software, artificial intelligence and partnerships supporting minimally invasive procedures.
Siemens Healthineers said it would stop selling general-imaging ultrasound systems, including Acuson Sequoia, Redwood, Juniper and Maple, from October 12, 2026. It will continue servicing existing customers and will sell procedural systems including Acuson Origin, P500 with intracardiac echocardiography and Freestyle, together with dedicated software and catheters.
Market context: Market report DAX.
